Skip to main content

TCR2 Therapeutics Inc.

TCRRDelisted Jun 1, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001750019

TCR2 Therapeutics Inc. was delisted on Jun 1, 2023; its insiders filed their last Form 4 on Feb 14, 2024; 59 institutions reported holding it in 13F filings for Q1 2023, worth $31.5M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding TCR2 Therapeutics Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of TCRR: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders94283−9
Shares27.1M46.8K24.9M−2.19M (−8.1%)
Value$74.8M$129.0K$72.2M−$2.51M (−3.4%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (14)

Institutions that held TCR2 Therapeutics Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to TCRR in Q2 2022
InstitutionSharesValue% of portfolio
K2 Principal Fund, L.P.1,078,070$3.13M0.53%
Newtyn Management, LLC692,799$2.01M0.38%
Oasis Management Co Ltd.200,000$580.0K0.11%
Ergoteles LLC147,400$427.0K0.01%
Cornercap Investment Counsel Inc47,452$138.0K0.02%
Squarepoint Ops LLC29,030$84.0K0.00%
Qube Research & Technologies Ltd26,180$76.0K0.00%
Orion Portfolio Solutions, LLC13,485$39.0K0.00%
Jane Street Group, LLC13,201$38.0K0.00%
LMR Partners LLP10,880$32.0K0.00%
Ellevest, Inc.258$1.00K0.00%
Wagner Wealth Management, LLC275$1.00K0.00%
Howe & Rusling Inc50$00.00%
Credit Suisse AG16$00.00%

Sold out (23)

Institutions that held TCR2 Therapeutics Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (2)

Institutions that held TCR2 Therapeutics Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TCRR in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC43,123$119.0K
Amalgamated Financial Corp.3,672$10.0K